Merck Consolidated Income Statement Audited

Sales

[22]

10,700.1

10,740.8

Royalty, license and commission income

[23]

395.0

432.1

Total revenues

11,095.1

11,172.9

Cost of sales

[24]

–2,992.5

–3,157.7

Gross margin

8,102.6

8,015.2

Marketing and selling expenses

[25]

–2,326.5

–2,410.8

Royalty, license and commission expenses

[26]

–567.0

–579.8

Administration expenses

[27]

–562.4

–552.2

Other operating expenses and income

[28]

–718.1

–1,125.9

Research and development costs

[29]

–1,504.3

–1,511.3

Amortization of intangible assets

[30]

–813.5

–871.6

Operating result

1,610.8

963.6

Financial result

[31]

–222.2

–254.6

Profit before income tax

1,388.6

709.0

Income tax

[32]

–179.5

–130.0

Profit after tax

1,209.1

579.0

of which attributable to Merck KGaA shareholders (net income)

1,202.2

566.7

of which attributable to non-controlling interests

[33]

6.9

12.3

Earnings per share (in €)

[34]

basic

5.53

2.61

diluted

5.53

2.61